Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Statin OTC Switch Debate Reflects Poorly On Physicians - FDA's Woodcock

Executive Summary

The discussion of switching cholesterol agents to over-the-counter status may reflect the failure of physicians to provide adequate counseling to patients, FDA Center for Drug Evaluation & Research Director Janet Woodcock, MD, told the agency's OTC switch public hearing June 29.

You may also be interested in...



FDA OTC Switch Policy: Key Issue Is Crafting Labeling From Public Domain

FDA is considering holding a public meeting to discuss Rx-to-OTC switch issues to clarify the agency's current thinking on which prescription categories have the potential to move over-the-counter in the near future

FDA OTC Switch Policy: Key Issue Is Crafting Labeling From Public Domain

FDA is considering holding a public meeting to discuss Rx-to-OTC switch issues to clarify the agency's current thinking on which prescription categories have the potential to move over-the-counter in the near future

Gynetics Exec Supports Restricted Access For OTC Emergency Contraceptives

Emergency contraceptive maker Gynetics would support age requirements and other restrictions on over-the-counter access to emergency contraception products, Gynetics Chief Financial and Operating Officer Jack Stover suggested to an FDA Rx-to-OTC switch public meeting June 29.

UsernamePublicRestriction

Register

LL005491

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel